News: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

40.06USD
19 Dec 2014
Price Change (% chg)

$-0.29 (-0.72%)
Prev Close
$40.35
Open
$40.24
Day's High
$40.58
Day's Low
$38.23
Volume
1,532,488
Avg. Vol
757,904
52-wk High
$40.58
52-wk Low
$27.51

Search Stocks
Select another date:

Wed, Sep 24 2014

Deals of the day- Mergers and acquisitions

(Adds Lindt & Spruengli, Yildiz Holding, Chiquita, Cisco, BASF SE, Actavis, Tibco, Discovery Communications Inc, Acorda Therapeutics)

Acorda buys Civitas to gain access to Parkinson's drug

- Acorda Therapeutics Inc said it bought privately held Civitas Therapeutics for $525 million to gain access to a Parkinson's disease drug in late-stage development.

UPDATE 2-Acorda buys Civitas to gain access to Parkinson's drug

(Adds comments from conference call, updates share movement)

Acorda buys Civitas to gain access to Parkinson's drug

Sept 24 - Biotechnology company Acorda Therapeutics Inc said it bought privately held Civitas Therapeutics for $525 million to gain access to a Parkinson's disease drug in late development.

Select another date:
Search Stocks